However, in vivo, IL-6 showed beneficial effects in early stages of disease due to induction of plaque clearance (Chakrabarty et al., 2010) and IL-6-deficient mice showed enhanced neuronal vulnerability in a MPTP-induced Parkinson model (Bolin et al., 2002). This evidence concerns the gene IL6 and Parkinsonism.